# Effects of Amorphous Calcium Carbonate Supplementation on Bone Health in Postmenopausal Women With Osteopenia

> **NCT05810909** · NA · COMPLETED · sponsor: **Universal Integrated Corp.** · enrollment: 35 (actual)

## Conditions studied

- Calcium
- Osteopenia
- Bone Mineral Density
- Bone Turnover Marker

## Interventions

- **DIETARY_SUPPLEMENT:** amorphous calcium carbonate/ Placebo

## Key facts

- **NCT ID:** NCT05810909
- **Lead sponsor:** Universal Integrated Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-10
- **Primary completion:** 2021-12-10
- **Final completion:** 2022-09-22
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2023-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05810909

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05810909, "Effects of Amorphous Calcium Carbonate Supplementation on Bone Health in Postmenopausal Women With Osteopenia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05810909. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*